Stroke study: HD-tACS
Official title Transcranial Alternating Current Stimulation (tACS) for the Recovery of Phonological Short-Term Memory in Patients With Aphasia After Stroke
ClinicalTrials.gov ID: NCT06048159
What this study is testing
- What it's testing
- This study aims to find out if a specific type of brain stimulation can help improve short-term memory for sounds in speech after a stroke.
- Who it's for
- The study is looking for adults who have had a stroke and are experiencing aphasia (difficulty with speaking or understanding language).
- What's involved
- Participants will receive transcranial alternating current stimulation (tACS), which is a mild electrical current applied to the head, along with language therapy.
- Time commitment
- The source text does not specify the duration of the study or the number of visits required.
This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosed with left hemisphere stroke/aphasia
- Consent date \>= 1 month after stroke onset
- Fluent in English
- 18 years of age or older
You likely can't join if
- Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing
- Presence of major untreated or unstable psychiatric disease
- A chronic medical condition that is not treated or is unstable
- The presence of cardiac stimulators or pacemakers
- Contraindications to MRI or tACS, e.g. patients with metallic implants, and/or history of skull fractures, pregnancy, skin diseases
- History of ongoing or unmanaged seizures
See the full eligibility criteria
- Diagnosed with left hemisphere stroke/aphasia
- Consent date \>= 1 month after stroke onset
- Fluent in English
- 18 years of age or older
- Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing
- Presence of major untreated or unstable psychiatric disease
- A chronic medical condition that is not treated or is unstable
- The presence of cardiac stimulators or pacemakers
- Contraindications to MRI or tACS, e.g. patients with metallic implants, and/or history of skull fractures, pregnancy, skin diseases
- History of ongoing or unmanaged seizures
- History of dyslexia or other developmental learning disabilities
The study team makes the final eligibility decision.
Where it is enrolling
- Milwaukee, Wisconsin, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Milwaukee, Wisconsin, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.